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Zebrafish possess a unique yet poorly under-
stood capacity for cardiac regeneration. Here,
we show that regeneration proceeds through
two coordinated stages following resection of
the ventricular apex. First a blastema is formed,
comprised of progenitor cells that express pre-
cardiac markers, undergo differentiation, and
proliferate. Second, epicardial tissue surround-
ing both cardiac chambers induces develop-
mental markers and rapidly expands, creating
a new epithelial cover for the exposed myocar-
dium. A subpopulation of these epicardial cells
undergoes epithelial-to-mesenchymal transi-
tion (EMT), invades the wound, and provides
new vasculature to regeneratingmuscle. During
regeneration, the ligand fgf17b is induced in
myocardium, while receptors fgfr2 and fgfr4
are induced in adjacent epicardial-derived
cells. When fibroblast growth factors (Fgf) sig-
naling is experimentally blocked by expression
of a dominant-negative Fgf receptor, epicardial
EMT and coronary neovascularization fail,
prematurely arresting regeneration. Our find-
ings reveal injury responses by myocardial
and epicardial tissues that collaborate in an
Fgf-dependent manner to achieve cardiac
regeneration.
INTRODUCTION
Progenitor cell populations have been identified within
most mammalian organs, including skin, blood, bone, re-
productive tissues, skeletal muscle, kidney, lung, liver,
intestine, heart, and brain. These cells vary widely in fre-
quency, developmental potential, and the ability to regen-
erate damaged or lost tissue. The most highly regenera-tive is the multipotent hematopoietic stem cell (HSC). A
single HSC can reconstitute the entire hematopoietic sys-
tem of an irradiated mammal (Wagers et al., 2002; Shizuru
et al., 2005). By contrast, progenitor cells within themajor-
ity of mammalian organs restore those cells lost in the
course of normal organ function or after minor injury, but
cannot regenerate after major damage or removal of
structures.
Ischemic myocardial infarction causes irreversible cell
loss and scarring and is a major source of morbidity and
mortality in humans. Thus, the inability to replace dam-
aged cardiac muscle ranks among the most prominent re-
generative failures of mammals (Rubart and Field, 2006).
Recent attempts to identify cardiac progenitor cells have
revealed at least three rare cell populationswith the poten-
tial to generate new cardiomyocytes (CMs) postnatally
(Beltrami et al., 2003; Cai et al., 2003; Oh et al., 2003,
Laugwitz et al., 2005). c-kitposLinneg cells and islet1pos
cells both exist normally as undifferentiated or poorly dif-
ferentiated cells but will differentiate to a contractile phe-
notype under in vitro conditions. Moreover, islet1pos cells
were shown by genetic lineage tracing experiments to
give rise to a large percentage of CMs during development
and growth, while c-kitposLinneg cells contributed new
CMs when injected into rodent myocardial infarcts. The
discoveries of cardiac progenitor cells have exciting impli-
cations for cardiac biology and disease. Yet, it is unclear
why they fail to support natural regeneration after ische-
mic infarction or other injury paradigms.
Regeneration is an evolutionarily conserved feature of
vertebrate species. Nonetheless, selected nonmamma-
lian vertebrates, including urodele amphibians and teleost
fish, display an elevated regenerative spectrum, with
many more tissues capable of impressive regeneration.
For instance, certain newts or axolotls can regenerate
limbs, tail, spinal cord, retina, lens, jaws, portions of intes-
tine, and brain tissue. Also, these animals achieve a partial
regenerative response after mechanical damage to the
cardiac ventricle. Cell-cycle entry and mitoses are ob-
served in spared CMs, along with scarring (Oberpriller
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teleosts can displaymarked interspecies differences in re-
generation of their appendages, it is believed that the ca-
pacity for regeneration is an ancestral condition that has
occasionally been attenuated in the course of vertebrate
evolution (Scadding, 1977; Wagner and Misof, 1992).
Thus, most biologists suspect that machinery to optimize
regeneration from progenitor cells is present but lies dor-
mant in mammals.
By contrast with mammals, teleost zebrafish regenerate
cardiac muscle after major injury; therefore, study of this
process can illuminate how heart regeneration is naturally
optimized. Following resection of the apex of the zebrafish
ventricle, CM hyperplasia vigorously renews the myocar-
dium and restricts scar formation (Poss et al., 2002;
Raya et al., 2003). Very little is known about cellular and
molecular mechanisms of this process, including whether
an undifferentiated progenitor cell type contributes or how
nonmyocardial cell types participate. Over the past sev-
eral years, large-scale genetic screens (Chen et al., 1996;
Stainier et al., 1996), transgenic reporter strains (Lawson
and Weinstein, 2002), and lineage studies (Keegan et al.,
2005) have revealed critical aspects of cardiovascular de-
velopment in zebrafish embryos. Somemolecular mecha-
nisms are likely to be shared by embryonic cardiogenesis
and adult cardiac regeneration (e.g., myocardial differen-
tiation programs). However, heart regeneration invokes
multiple distinct and defining events, including (1) initiation
by injury, (2) activation of quiescent tissue, (3) ostensibly
local development as opposed to organ- and organism-
wide development, (4) simultaneous healing and growth,
(5) morphogenesis on a larger scale to form adult tissue,
and (6) possible long-term maintenance or de novo crea-
tion of progenitor cells.
Here, to identify and characterize key processes re-
sponsible for cardiac regeneration in zebrafish, we em-
ployed transgenic reporter strains, identified newmolecu-
lar markers for regenerating tissues, and performed
genetic loss-of-function studies. Our findings reveal dy-
namic, coordinated cellular and molecular events that
mediate heart regeneration.
RESULTS
Heart Regeneration Involves Changes in Myocardial
Differentiation
A hallmark of many regenerating systems, from the de-
capitated planarian to the amputated amphibian limb, is
formation of the regeneration blastema, a proliferative
mass of undifferentiated progenitor cells from which new
differentiated structures arise (Reddien and Sanchez-
Alvarado, 2004; Brockes and Kumar, 2005). Previous
studies did not investigate whether myocardial regenera-
tion in zebrafish utilizes a blastema or instead results
purely from expansion of existing CMs without changes
in differentiation (Poss et al., 2002; Raya et al., 2003).
To sensitively monitor changes in myocardial differenti-
ation during heart regeneration, we used transgenic ze-
brafish expressing a nuclear-localized DsRed2 fluores-608 Cell 127, 607–619, November 3, 2006 ª2006 Elsevier Inc.cent reporter for cmlc2 (cmlc2:nRFP, where RFP is red
fluorescent protein). Individual differentiated CMs were
predicted to show high levels of nuclear fluorescence
(RFPhi), while less differentiated or transitioning CMs
should display lower fluorescence (RFPlo). As expected,
CM nuclei in uninjured ventricles were uniformly RFPhi,
as were those in ventricles at 3 days after amputation
(dpa; Figure 1A). However, by 14 dpa and as early as 7
dpa, CM nuclei with dramatically lower RFP fluorescence
appeared at the apex. RFPlo cells were typically most
abundant at 22 dpa, at which time what appeared to be
the entire regenerate could in some cases be distin-
guished (Figure 1A). By 30 dpa, when a contiguous ven-
tricular wall was restored in our experiments, CM differen-
tiation as assessed by the reporter strain had recovered to
normal or near-normal levels (Figure 4D). Thus, heart re-
generation involves demonstrable changes in myocardial
differentiation.
New Myocardium Arises from Undifferentiated
Progenitor Cells
Analyses of cmlc2:nRFP animals at multiple times postre-
section suggested a mechanism in which undifferentiated
cells accumulate in the wound and differentiate into con-
tractile CMs. To confirm this mechanism, we examined
the developmental timing of myocardial differentiation
using double transgenic animals with both nRFP and
enhanced green fluorescent protein (EGFP) driven by
cmlc2 promoters. This approach takes advantage of the
different properties of these fluorescent proteins and can
reveal temporal and spatial characteristics of promoter
activation and inactivation (Verkhusha et al., 2001; Ver-
khusha et al., 2003). EGFP folds and fluoresces more rap-
idly than DsRed2 (Baird et al., 2000; Bevis and Glick,
2002)—approximately one day faster in embryonic zebra-
fish CMs activating the cmlc2 promoter for the first time
(Figure S1). EGFP is also less stable than DsRed2 and
degrades about twice as rapidly in vitro and in vivo (Ver-
khusha et al., 2003). This bidirectional developmental
timer allows us to (1) identify new CMs arising from an un-
differentiated state (EGFPposRFPneg cells), and (2) deter-
mine whether once-expressing CMs have switched off
the cmlc2 promoter as part of the regeneration program
(EGFPnegRFPpos cells).
In injured double transgenic ventricles, we never ob-
served EGFPnegRFPpos myocardium (n = 931 apical CMs
examined from 12 animals at 3 and 7 dpa), indicating
that the RFPlo cells do not result from a loss of the differ-
entiated state. At 3 and 4 dpa, myocardium was uniformly
EGFPposRFPpos, including the apical edge of the regener-
ate. At 5 dpa, myocardial tissue at the resection plane be-
gan to display some areas of EGFPposRFPneg tissue
(Figure 1B; Table S1). Strikingly, at 7 dpa, the apical myo-
cardial edge was uniformly EGFPposRFPneg, indicative of
a front of CMs newly differentiating from a noncontractile
state (Figure 1B). This EGFPposRFPneg front was also pres-
ent at 14 dpa but apically shifted (data not shown). Similar
results were observed with a double transgenic strain
Figure 1. New Myocardium Arises from Undifferentiated Progenitor Cells
(A) Sections through uninjured and injured cmlc2:nRFP ventricles. A subpopulation of RFPlo nuclei manifests by 14 dpa (arrowheads), representing
ostensibly the entire regenerate by 22 dpa. Magenta line in high-magnification insets delineates RFPhi CMs (above line) from RFPlo CMs.
(B) cmlc2:nRFP; cmlc2:EGFP ventricles. EGFP and RFP expression from the cmlc2 promoter is reported at the same basoapical level at 3 dpa. By 7
dpa, an RFPneg front of newly differentiated muscle reporting the faster-fluorescing EGFP (brackets) appears apical to the EGFPposRFPpos portion.
Arrowhead indicates an EGFPpos cell process extending into the clot.
(C) cmlc2:nRFP; cmlc2:EGFP ventricles stained for DsRed immunoreactivity with an anti-DsRed antibody. At 3 dpa, there is no difference in appear-
ance from the unstained 3 dpa ventricle in (B). By 7 dpa, a front of RFPcyto muscle (arrowheads), representing the most recently differentiated CMs,
colabels EGFPpos tissue apical to natural RFPnuc fluorescence. Scale bar = 100 mm.reporting nRFP from the cmlc2 promoter and EGFP from
the promoter for b-actin 2, another gene expressed
strongly in CMs (data not shown). These results indicated
that regenerating myocardium matures from undifferenti-
ated, Cmlc2-negative cells established at the amputation
plane within 5 days of apical resection.
We confirmed this finding with an additional develop-
mental timing assay using an antibody against DsRed. A
previous study using transgenic Drosophila embryos ex-
pressing DsRed behind the hedgehog promoter found
that DsRed immunoreactivity is detectable many hours
before and anterior to natural RFP fluorescence during
posterior-to-anterior differentiation of eye ommatidia (Aki-
moto et al., 2005). Sections of 3 dpa cmlc2:nRFP;
cmlc2:EGFP ventricles stained with the anti-DsRed anti-
body appeared identical to unstained sections (Figures
1B and 1C). However, DsRed immunoreactivity apical to
natural RFP fluorescence was detectable as early as 4–5
dpa, labeling precisely the EGFPposRFPneg apical edge
of the regenerate at 7 dpa (Figure 1C; Table S1). Thus,new myocardium matures from an undifferentiated popu-
lation of progenitor cells.
Cardiac Progenitors Initiate a Wave of Regenerative
Morphogenesis
Serendipitously, CMs at the apical edge of the regenerate
displayed a conspicuous cytosolic RFP (RFPcyto) profile
when stained with the anti-DsRed antibody, representing
nonfluorescent RFP translation product that is slow to
fold and accumulate in the nucleus. In regenerating
hearts, RFPcyto CMs were absent at 3 dpa and rare at 4
dpa. By 5 and 7 dpa, large, RFPcyto CMs were abundant
within a contiguous front at the apical edge of the regen-
erate (Figure 1C; Table S1). We suspected that RFPcyto
cells were freshly differentiated CMs activating the
cmlc2 promoter for the first time, and we tested this idea
with embryonic cmlc2:nRFP hearts. As predicted, 24 hpf
embryonic CMs (having no natural RFP fluorescence)
showed a full RFPcyto profile and 48 hpf hearts had a sub-
set of RFPcyto CMs among mostly RFPnuc CMs, whileCell 127, 607–619, November 3, 2006 ª2006 Elsevier Inc. 609
60 hpf CMs displayed essentially complete nuclear RFP
localization (Figure S2). This similarity in DsRedmaturation
kinetics between early CMs of the adult regenerate and of
the embryonic heart suggested that a precardiac field akin
to the embryonic heart field is formed and bears new CMs
during cardiac regeneration.
In the embryonic zebrafish heart field, cardiac progeni-
tors are identified by their expression of transcriptional ac-
tivators of myocardial differentiation in lateral plate meso-
derm several hours before induction of cmlc2 (Chen and
Fishman, 1996; Griffin et al., 2000; Yelon et al., 2000).
We found that nkx2.5, hand2, and tbx20, the earliest
markers of the embryonic zebrafish heart field, were also
the earliest detectable precardiacmarkers during heart re-
generation. hand2 was detectable by in situ hybridization
(ISH) in cells coating the apical myocardial edge at 3 dpa,
while nkx2.5 and tbx20 were first detectable in a similar
population lining the existing muscle by 4 dpa. Because
of their localization and emergence prior to evidence of
significant new CM differentiation (Figure 2A; Table S1),
these hand2/nkx2.5/tbx20-positive cells most likely repre-
sent progenitor cells that have recently acquired a cardiac
fate. A domain of conspicuously enhanced expression of
these markers as well as other transcriptional activators
Mef2 and tbx5 was present at the apical edge of the re-
generate at 5 and 7 dpa, correlating with the differentiating
front of new CMs defined by developmental timing assays
(Figure 2B; Table S1).
Previous studies showed that proliferation of CMs is
a prominent feature of zebrafish heart regeneration, initi-
ated around 7 dpa and peaking by 14 dpa (Poss et al.,
2002). Indeed, a significant amount of myocardial regen-
eration occurs in the second week after resection (Fig-
ure 2). We observed RFPcyto CMs at the apical edge of
the regenerate at 14 dpa, mainly comprised of smaller
CMs that most likely contribute compact myocardium of
the ventricular wall (Figure 2C). A domain of enhanced pre-
cardiac marker expression was also detectable here at
14 dpa, becoming less prominent as regeneration pro-
gressed (Figure 2C; Table S1). To determine whether car-
diac progenitors facilitate CMproliferation during regener-
ation, we labeled cmlc2:nRFP animals with BrdU at 7 or
14 dpa and assessed CM differentiation using the anti-
DsRed antibody. At 7 dpa, BrdU labeling was specific to
freshly differentiated, RFPcyto CMs, with little or no incor-
poration in established RFPnuc CMs. At 14 dpa, BrdU in-
corporation was seen in both RFPnuc and RFPcyto CMs
(Figure 2D). Thus, our data indicate that the precardiac
field is a source of CMs with the capability to proliferate
and carry out regeneration. This finding is consistent
with our previous study in which we identified the apical
edge as a proliferative front during regeneration (Poss
et al., 2002).
In total, our experiments reveal that new myocardium
forms from an undifferentiated field comparable to a blas-
tema, comprised of progenitor cells that associate with
existingmyocardiumwithin 3–4 days of injury, activate ex-
pression of precardiac markers, and differentiate into pro-610 Cell 127, 607–619, November 3, 2006 ª2006 Elsevier Inc.liferative CMs. After this initial seeding of progenitor cells,
regenerative morphogenesis proceeds in a basal-to-
apical wave of progenitor cell seeding, maturation, and
proliferation.
Cardiac Injury Activates the Entire Epicardial Cell
Layer
Another hallmark of many regenerating systems is emer-
gence of a multi-layered epithelial structure called the
wound (or regeneration) epidermis, which forms over the
blastema bymigration of spared epithelial cells. For exam-
ple, in the regenerating fin, epidermal and blastemal tis-
sues interact throughout regeneration to catalyze mor-
phogenesis, events that involve epidermal synthesis and
blastemal reception of growth factors (Poss et al., 2000).
We predicted that regenerating myocardium would re-
quire interaction with the epicardium, an easily distin-
guishable epithelial cell layer that envelops all peripheral
surfaces of the heart and influences myocardial develop-
ment in the embryo. To assess epicardial activity during
regeneration, we followed expression of raldh2 and
tbx18, genes expressed in the developing embryonic epi-
cardium (Moss et al., 1998; Kraus et al., 2001).
Epicardial cells of the uninjured adult heart showed little
or no expression of raldh2, which encodes the rate-limit-
ing enzyme for retinoic acid (RA) synthesis. Surprisingly,
as early as 24 hr after partial ventricular amputation
(hpa), raldh2 was strongly induced in epicardium sur-
rounding the ventricle, atrium, and outflow tract (Fig-
ure 3A). Induced expression of raldh2 appeared sequen-
tially, first in the outflow tract and atrial epicardium by
6–12 hpa and then joined by the ventricular epicardium
(data not shown). Ventricular and atrial epicardial cells
also expressed tbx18 by 1–2 dpa (Figure 3B) and began
to proliferate (Figure 3C). BrdU-labeling experiments
demonstrated robust, S phase entry of most raldh2/
tbx18-positive epicardial cells at 3 dpa. By 7 dpa, this re-
sponse began to localize to the injured ventricular apex,
where BrdU-labeled epicardial cells enclosed the wound
(Figures 3C and 3D). By 14 dpa, activated epicardium
was confined to the wound (Figures 3A, 3B, and 3D).
Thus, a focal ventricular injury stimulates organ-wide, de-
velopmental activation of the adult zebrafish epicardium,
the expansion of which creates an epithelial cover for
regenerating myocardium.
Epicardial-Derived Cells Invade and Vascularize
the Regenerating Myocardium
Epicardial cells at the apex of the injured ventricle not only
enveloped the wound but also displayed a remarkable in-
vasive behavior. While raldh2 expression began to sub-
side in epicardial cells by 14 dpa, a large number of cells
retained tbx18 expression and integrated into the wound
and new muscle. Even by 30 dpa, many tbx18-positive
cells were maintained in the regenerate (Figure 3D). These
invasion events were reminiscent of embryonic heart de-
velopment, during which epicardial cells undergo epithe-
lial-to-mesenchymal transition (EMT) and invade the
Figure 2. A Precardiac Field Is Established during Regeneration and Supports CM Proliferation
(A) The precardiacmarker hand2 is expressed in cells coating the apical edge of the existing muscle at 3 dpa (violet stains). At 4 dpa, nkx2.5 and tbx20
are also expressed in cells distributed along the resection plane. By contrast, no newCMdifferentiation events are detected by anti-DsRed staining in
cmlc2:nRFP zebrafish at 3 dpa (see Figure 1) and only sparse events at 4 dpa (Table S1). The pink background represents myocardial autofluores-
cence, which aids visualization of positive signals.
(B) nkx2.5, tbx20, hand2, tbx5, and Mef2 (red nuclear stain) are each present in a domain of enhanced expression at the apical edge of the regenerate
(brackets), an area of most recent myocardial differentiation events as assessed in the cmlc2:nRFP; cmlc2:EGFP strain. The ISH pattern of cmlc2 at 7
dpa is also shown to indicate differentiated muscle.
(C) By 14 dpa, freshly differentiated RFPcyto cells in cmlc2:nRFP; cmlc2:EGFP hearts appear smaller and remain at the apical edge as regeneration
proceeds (brackets). Enhanced nkx2.5, tbx20, and hand2 expression remains detectable in this region.
(D) Seven (left) and 14 dpa (right) ventricles from cmlc2:nRFP zebrafish stained for DsRed immunoreactivity (red) and BrdU incorporation (green). At 7
dpa, BrdU label is detectable only in newly differentiated RFPcyto cells (arrowheads). By 14 dpa, BrdU is also detectable in RFPnuc CMs (arrows). Scale
bar = 100 mm.Cell 127, 607–619, November 3, 2006 ª2006 Elsevier Inc. 611
Figure 3. Organ-Wide Activation of Epicardial Cells and Invasion of the Regenerate
(A and B) Whole-mount (top) and section (bottom) ISH of uninjured and 3 and 14 dpa hearts for raldh2 (A) and tbx18 (B). Expression of each marker is
low or undetectable in the uninjured hearts but induced at 3 dpa in epicardial tissue surrounding the atrium (a) and ventricle (v) for tbx18 and these
tissues plus the outflow tract (o) for raldh2. The endocardium surrounding wounded myofibers also expresses raldh2. By 14 dpa, expression of both
markers is localized to the apical wound (arrowhead).
(C) Colocalization of BrdU (green) with raldh2 (top) and tbx18 (bottom) in the ventricular epicardium at 3 and 7 dpa. The left images display a lateral
edge of the 3 dpa ventricle away from the wound, while the right images display a lateral and apical portion of the 7 dpa ventricle including some of the
wound. By 7 dpa, raldh2/tbx18/BrdU-positive cells begin to localize to the injury site. The majority of nonepicardial BrdU-positive cells are erythro-
cytes within the ventricular lumen.
(D) Epicardial-derived cells positive for tbx18 invade the regenerate by 7 dpa and remain by 30 dpa. Scale bar = 100 mm.subepicardial space and myocardium. Following these
EMT events, epicardial-derived cells generate endothelial
and smooth muscle cells of the subepicardial and coro-
nary vasculature (Dettman et al., 1998; Olivey et al., 2004).
To identify vascular changes during heart regeneration,
we used fli1:EGFP transgenic zebrafish that report fluo-
rescence in endothelial cells. Coronary vasculature was
easily distinguishable from the endocardial endothelium
by its location, shape, and stronger intensity of fluores-
cence (Figure 4A) and was similarly distinguishable in ven-
tricles of flk1:EGFP transgenic zebrafish (data not shown).
We found an extensive network of new coronary vessels in
cmlc2:nRFP; fli1:EGFP regenerates by 14 dpa, coincident
with the appearance of epicardial-derived cells. This cor-
onary plexus penetrated regions of differentiating RFPlo
CMs at 14 dpa andwas stablymaintained in 30 dpa regen-
erates (Figures 4B–4D). Our results indicate that develop-
mentally activated epicardial cells invade the newmyocar-
dium and create a dense vascular network likely to
encourage regeneration.612 Cell 127, 607–619, November 3, 2006 ª2006 Elsevier Inc.Fgf Signaling Promotes Epicardial EMT
and Coronary Neovascularization, Facilitating
Myocardial Regeneration
Why do activated epicardial cells preferentially penetrate
and vascularize regenerating myocardium? In vitro stud-
ies have shown that fibroblast growth factors (Fgfs) pro-
mote epicardial EMT into collagen gels (Morabito et al.,
2001). To determine whether Fgfs help recruit epicardial
cells into cardiac wounds and regenerating muscle, we
examined expression by ISH of multiple Fgf ligands and
all 4 Fgfr receptors (Fgfrs) during regeneration. fgf17b,
a member of the Fgf8/17/18 subclass of Fgf ligands
(Cao et al., 2004), was the only ligand gene that showed
detectable expression among several we tested (Fig-
ure 5A). In uninjured and 3 dpa ventricles, fgf17b was
faintly detectable in cardiac myofibers. By 7 dpa, expres-
sion of fgf17bmRNAwas strongly enhanced in CMs at the
apical edge of the regenerate. Other cell types within the
injury also expressed fgf17b at this stage. This augmented
expression persisted at 14 dpa; by 30 dpa, the new
Figure 4. Enrichment of Coronary Vasculature during Regeneration
cmlc2:nRFP; fli1:EGFP ventricles displaying RFP fluorescence in CM nuclei (top) and EGFP in endocardial and vascular endothelial cells (middle).
(A) Weak EGFP fluorescence is emitted from endocardial cells that surround internal trabecular myofibers, while more intense fluorescence is re-
ported in endothelial cells of the coronary vasculature (arrowheads).
(B) As early as 7 dpa, coronary vasculature begins to appear in the wound. Magenta line in high magnification inset delineates RFPhi CMs (above line)
from RFPlo CMs.
(C) By 14 dpa, regenerating myocardium, identifiable as RFPlo, is heavily vascularized.
(D) Myocardial differentiation has essentially recovered by 30 dpa, and the apical regenerate retains an extensive coronary network. Scale
bar = 100 mm.myocardial wall contained many cells with enhanced
fgf17b expression.
Among zebrafish Fgf ligands, Fgf17b shows the highest
homology to mammalian Fgf17, which binds receptors
Fgfr1-3 (the ‘‘c’’ spliced forms) and Fgfr4 (Olsen et al.,
2006). In the uninjured adult zebrafish heart, smooth mus-
cle cells in the outflow tract expressed fgfr1 and fgfr2, and
valve mesenchyme expressed fgfr1, fgfr2, and fgfr4 (data
not shown). We did not detect by ISH expression of any
fgfrs in the uninjured ventricular myocardium, nor did
this tissue express fgfrs after injury. Interestingly, we de-
tected expression of fgfr2 and fgfr4, but not other fgfrs,
in epicardial tissue during regeneration. fgfr4 was ex-
pressed in rare epicardial cells around the periphery of
the uninjured ventricle (Figure 5C). By 3 dpa, fgfr4was ex-
pressed in a slightly greater number of ventricular epicar-
dial cells, although no cells in thewound expressed fgfrs at
this time (data not shown). More remarkable was the ex-
pression of fgfr2 and fgfr4 in contiguous stretches of atrial
epicardial cells at 3 dpa, far removed from the injury and
reminiscent of raldh2 and tbx18 patterns (Figure S3). As
regeneration continued, expression of these receptors re-
sembled that of tbx18 in particular, and, using double ISH,
we found that fgfr4 was expressed in a subpopulation of
tbx18-positive cells adjacent to the apical edge of the re-generate (Figure S3). By 7 dpa, fgfr2 and fgfr4 were in-
duced in epicardial cells within or at the lateral edges of
wounds. By 14 dpa, each receptor was expressed in cells
that had integrated into the wound and regenerating mus-
cle, expression that persisted within the regenerate at
30 dpa (Figures 5B and 5C). Together, the temporal and
spatial expression patterns of these genes suggested
that Fgf17b released from the regenerating myocardium
signals to fgfr2/4-expressing, epicardial-derived cells.
To directly test the function of Fgf signaling during car-
diac regeneration, we used animals transgenic for a heat-
inducible, dominant-negative Fgfr tagged with EGFP
(hsp70:dn-fgfr1). In a previous study, we found that daily
heat treatments of hsp70:dn-fgfr1 animals effectively pre-
vent regeneration of amputated fins (Lee et al., 2005). Fur-
thermore, a single heat shock strongly and uniformly in-
duced dn-fgfr1 transgene expression in cardiac cells for
more than 24 hr (Figure S4). To determine whether Fgfr ac-
tivation is required for heart regeneration, we exposed
wild-type and hsp70:dn-fgfr1 clutchmates to 7, 14, and
30 days of daily heat induction after ventricular resection
surgery. Formation of differentiated myocardium was as-
sessed by ISH using a probe for cmlc2. hsp70:dn-fgfr1
animals showed no differences from wild-types by 7 dpa
(n = 6 animals) but presented slightly larger woundsCell 127, 607–619, November 3, 2006 ª2006 Elsevier Inc. 613
Figure 5. Expression of fgf17b, fgfr2, and
fgfr4 during Heart Regeneration
(A) Expression of fgf17b in the uninjured, 7, 14,
and 30 dpa heart visualized by ISH.Weak, peri-
nuclear expression was observed in uninjured
ventricular CMs. Starting at 7 dpa, myofibers
at the apical edge of the regenerate showed
enhanced fgf17b expression (arrowheads), as
did other cells within and around the injury.
This augmentation persisted in regenerating
muscle through 30 dpa.
(B) Expression of fgfr2 during heart regenera-
tion. While the uninjured ventricle showed no
fgfr2 expression, epicardial cells induced fgfr2
upon entering the wound at 7 dpa (arrow-
heads), where expression was strongest at
14 dpa. By 30 dpa, faint expression was ob-
served in isolated cells within the regenerate
(arrowheads).
(C) fgfr4 is expressed in a small number of epi-
cardial or subepicardial cells on the uninjured
ventricle (arrowheads) and induced in cells ad-
jacent to regenerating muscle at 7 dpa and 14
dpa. fgfr4-expressing cells remain detectable
in the regenerate by 30 dpa; in this image,
fgfr4 expression in the valve can also be ob-
served (upper right corner). Scale bar = 100 mm.(cmlc2-negative tissue) by 14 dpa (n = 12). While the ma-
jority of wild-type animals restored a contiguous cmlc2-
positive ventricular wall by 30 dpa, hsp70:dn-fgfr1 ventri-
cles continued to display prominent wounds (n = 20;
Figure 6A). A second, independent line of hsp70:dn-fgfr1
zebrafish showed identical defects at 30 dpa (data not
shown). Instead of completing regeneration, transgenic
fish retained substantial fibrin deposits and developed
large, collagen-rich scars. Analysis of later times postin-
jury indicated that the fibrin was eventually replaced by
additional scar tissue (data not shown). By contrast,
wild-type ventricles displaced wound fibrin with myocar-
dium by 30 dpa and displayed only small collagen de-
posits (n = 14; Figure 6B). These results demonstrate
that heart regeneration is an Fgf-dependent process.
To determine whether this regenerative failure was
caused by defects in epicardial-derived cells, we as-
sessed tbx18 expression at 14 and 30 dpa in hsp70:dn-
fgfr1 animals. In the absence of Fgf signaling, tbx18-pos-
itive epicardial cells enveloped the wound normally by 14
dpa. However, instead of integrating into the clot or into
regenerating muscle, these cells accumulated on the pe-
riphery of the apex (n = 9; Figure 6C). This phenotype
did not result from developmental delay, as tbx18-positive
cells continued to remain on the periphery by 30 dpa (n =
10). To determine the effects of this deficiency on the
epicardial-derived coronary plexus, we assessed hsp70:
dn-fgfr1; fli1:EGFP double transgenics. Vessels were ob-614 Cell 127, 607–619, November 3, 2006 ª2006 Elsevier Inc.served in some cases at the apical edge of the clot mate-
rial in these animals. Strikingly, we found little or no
organized endothelium within the wound and adjacent
to muscle at 14 or 30 dpa, indicating a severe failure in
coronary neovascularization (n = 8; Figure 6D). Consistent
with our failure to detect myocardial expression of fgfr
genes during regeneration, assays for tbx20 expression
and RFP fluorescence in injured hsp70:dn-fgfr1 or
hsp70:dn-fgfr1;cmlc2:nRFP hearts at 14 dpa indicated
no gross disruption of the adult myocardial differentiation
program per se (n = 8; Figure S5).
Our findings demonstrate that Fgf signaling is seminal to
the regenerative capacity of the zebrafish heart. This path-
way, ostensibly stimulated in Fgfr2/4-expressing epicar-
dial cells by myocardial Fgf17b, is essential to promote
epicardial EMT into regenerating myocardium. Without
this recruitment of epicardial cells, coronary neovasculari-
zation fails, limiting myocardial regeneration and enabling
scar formation.
DISCUSSION
Zebrafish Heart Regeneration Is Initiated by
Progenitor Cells
Our experiments reveal several new mechanistic insights
into zebrafish heart regeneration, from which we propose
a model (Figure 7). First, developmental timing assays
using transgenic reporters of contractile gene expression
Figure 6. Fgfr Inhibition Blocks Epicardial EMT, Disrupting Coronary Neovascularization and Arresting Regeneration
(A) cmlc2 expression at 7, 14, and 30 dpa in heat-inducedwild-type and hsp70:dn-fgfr1 zebrafish. Transgenic animals arrested regeneration of cmlc2-
positive differentiated muscle around 14 dpa, leaving a large wound by 30 dpa.
(B) Thirty dpa hearts stained with acid fuchsin-orange G (AFOG). Wild-type ventricles display small deposits of scar tissue (blue) within a restored
myocardial wall, while hsp70:dn-fgfr1 hearts retain large amounts of fibrin (orange) and collagen (blue).
(C) Wild-type and hsp70:dn-fgfr1 ventricles at 14 and 30 dpa, stained for tbx18 expression by ISH. Wild-type tbx18-positive cells integrate into the
regenerating muscle, but hsp70:dn-fgfr1 tbx18-positive cells fail to integrate and accumulate at the apical edge of the wound. Clot material is outlined
in red.
(D) Wild-type fli1:EGFP and hsp70:dn-fgfr1; fli1:EGFP ventricles at 14 and 30 dpa. Wild-type regenerates are well vascularized (region within arrow-
heads). By contrast, transgenic wounds developed little or no organized endothelial structures in the vicinity of muscle. Occasionally, vessels were
seen on the periphery of the wound, as indicated by arrowheads in these ventricles. hsp70:dn-fgfr1 ventricles also display heat-induced fluorescence
from the EGFP-tagged transgene. Scale bar = 100 mm.revealed that regeneration is initiated predominantly by
undifferentiated progenitor cells. Beginning at 3–4 days
of injury, these cells localize at the apical edge of existing
myocardium, activate precardiac and contractile gene ex-
pression, and proliferate. Thus, formation of the blastema
constitutes the first stage of heart regeneration.
This mechanism is somewhat unexpected, as the sim-
plest explanation from previous studies was that existing
CMsdivide in response to injurywithout changing contrac-
tile status. That same interpretation is inferred fromstudies
of cultured newt CMs, a subpopulation of which divide in
culturewithno reportedchange in contractile geneexpres-
sion (Bettencourt-Dias et al., 2003). We speculate that in-
jury-related signals are insufficient to stimulatemeaningful
proliferation from existing adult zebrafish cardiac muscleCand that progenitor cells contribute CMs with increased
mitotic capacity. Determining signals that assist these pro-
genitor cells to naturally assimilatewith existingmyofibers,
mature, and proliferate will help to understand how myo-
cardial regeneration can best be supported by progenitor
cells in mammalian cardiac biology and disease.
During urodele lens, tail, and limb regeneration, there is
evidence that structural cells lose functional characteris-
tics or dedifferentiate to contribute progenitor cells to
the blastema (Eguchi et al., 1974; Lo et al., 1993; Echeverri
and Tanaka, 2002). Although we used a sensitive develop-
mental timing assay capable of detecting myocardial de-
differentiation, we did not identify CMs with a prolonged
arrest of contractile gene expression after injury. Further-
more, the apical edge of the regenerate expressedell 127, 607–619, November 3, 2006 ª2006 Elsevier Inc. 615
Figure 7. Model for Zebrafish Heart
Regeneration
Resection of the ventricular apex stimulates
rapid expansion of the entire epicardium by 3
dpa (black dots), at which time myocardial pro-
genitor cells first originate in the wound, ex-
press precardiac markers, and associate with
existing muscle. By 7 dpa, raldh2/tbx18-posi-
tive epicardial cells begin to surround and in-
vade the wound. Meanwhile, there is continued
seeding, maturation, and proliferation of myo-
cardial progenitor cells, contributing the first
layers of new muscle (stage 1).
To coordinate these epicardial and myocardial
events, regenerating myocardium synthesizes
Fgf17b and possibly other factors with the
potential to recruit Fgfr2/Fgfr4-presenting epi-
cardial cells. Epicardial-derived cells undergo
EMT in response and vascularize the regener-
ate (green dots). Presence of new coronary
vasculature by 14 dpa extends progenitor cell
activity and facilitates restoration and expan-
sion of the ventricular wall (stage 2).increased levels of the myocardial differentiation activa-
tors nkx2.5, tbx20, hand2, tbx5, and Mef2. Therefore,
while our data do not rule out rare or rapid dedifferentiation
events, they better support the idea that myocardial pro-
genitors originate primarily from an existing or injury-acti-
vated reserve. Potential sources for these cells, first iden-
tifiable in our experiments by their expression of hand2,
may be similar to identifiedmammalian cardiac progenitor
cell populations or could even include cardiac cell types
like epicardium or endocardium. Interestingly, we have
assessed expression of islet1, islet2, and islet3, as well
as kita and kitb, during heart regeneration but found no
detectable expression by ISH at 7 dpa (unpublished
observations). Continued pursuit of unique markers for
zebrafish myocardial progenitor cells and application of
Cre-mediated genetic lineage labeling techniques (Cai
et al., 2003; Meilhac et al., 2003) should help to address
the intriguing question of how these cells arise.
Cardiac Injury Causes Organ-Wide Epicardial
Augmentation
Second, we identified immediate and organ-wide trans-
mission and reception of the cardiac injury signal in epi-
cardial tissues. By 3 dpa, an abundance of developmen-
tally activated epicardial tissue covered the heart,
enveloping the wound by 7–14 dpa. Very little is known
about the function of the epicardium encasing the adult
vertebrate heart. Our results show that the adult zebrafish
epicardium is a highly plastic and responsive structure,
performing analogously to the classic regeneration epi-
dermis that revitalizes an amputated appendage.
How cardiac injury augments the entire epicardial layer
is unknown. Organ-wide injury responses are known to
occur during other displays of regeneration. For example,
in the adult mammalian liver, partial hepatectomy stimu-
lates proliferation in approximately 95% of remaining he-616 Cell 127, 607–619, November 3, 2006 ª2006 Elsevier Inc.patocytes (Taub, 2004). Recently, it was found that the
efficacy of liver regeneration is modified through feedback
mechanisms that gauge its ability to produce bile acids
(Huang et al., 2006). An analogous idea is that myocardial
integrity is somehow assessed biochemically by its output
and that a feedbackmechanismmay have an initial organ-
wide effect to increase epicardial tissue.
New epicardial cells could either be derived by stimula-
tion of the quiescent adult epicardium or from a progenitor
cell population transformed by injury. Relevant to the
latter, it is interesting that the spatial and temporal proper-
ties of the regenerative epicardial response mimic the
basal-to-apical manner in which an epithelial sheet first
emerges from the proepicardial organ (PEO) at the embry-
onic atrioventricular (AV) junction to cover the growing
cardiac chambers (Reese et al., 2002). Therefore, it is
possible that there is an analogous structure to the PEO
located at the adult AV junction, one that can generate
proliferative, migratory epicardial tissue in response to
injury. In any case, the large epicardial pool that is created
after injury ostensibly expedites identification of the
damaged muscle and optimizes subsequent EMT and
neovascularization.
Targeted, Fgf-Dependent Epicardial EMT Maintains
Heart Regeneration
Third, our study revealed a mechanism by which the acti-
vated epicardium supports the activities of cardiac pro-
genitor cells, constituting the second stage of regenera-
tion (Figure 7). Within two weeks after injury, epicardial
cells expressing raldh2 and tbx18 localize to the wound.
Here, not only do these cells provide cover for the naked
myocardium, but a subpopulation retains tbx18 expres-
sion, undergoes EMT, penetrates the regenerate, and ulti-
mately settles many cell layers deep into the muscle to
establish new vascular tissue.
We have found that epicardial cells express Fgf recep-
tors as they approach the wound, and moreover, Fgf sig-
naling is essential for their recruitment into regenerating
muscle. While multiple sources and forms of Fgfs might
be present during regeneration, Fgf17b synthesis is in-
creased in wounded/regenerating myocardium from 7 to
30 dpa and is an excellent candidate to attract epicar-
dial-derived cells expressing fgfr2 and/or fgfr4. Such co-
ordination of epicardial and myocardial activities by Fgf
signaling to vascularize newCMs represents aprovocative
mechanism to maintain and extend heart regeneration af-
ter the blastema is formed. It is likely that such an interac-
tion represents one arm of a regulatory loop involving nu-
merous signals between epicardium and myocardium.
During embryonic heart development, the transcription
factor FOG2 is required in the growingmyocardium for the
formation of coronary vasculature (Tevosian et al., 2000).
This finding demonstrated that normal development of
epicardial-derived tissues requires signals from the myo-
cardium. Furthermore, in addition to in vitro effects of
Fgfs on epicardial EMT mentioned earlier, recent studies
indicate that experimentally augmenting the concentra-
tion of Fgfs in the myocardium of the developing avian
heart by retroviral expression can increase the density of
coronary vessels (Pennisi andMikawa, 2005). Finally, a re-
cent study showed that Fgf signaling is required for normal
vascularization of the developing murine heart, possibly
through interactions with Vegf and Hedgehog signaling
pathway members (Lavine et al., 2006). The embryonic
heart is a highly tractable model for understanding cardio-
genesis, and we expect that studies of embryonic heart
development and adult heart regeneration will together
yield valuable comparisons. Our current study illustrates
that the regenerating heart can recall signaling pathways
essential during its embryonic manifestation.
Myocardial Regeneration Utilizes a Vascularized
Niche
We have found that regeneration by zebrafish myocardial
progenitor cells is optimized within a fostering niche that
includes a regeneration epidermis and an abundant vas-
cular supply. Blood vessels, as well as specific compo-
nents of endothelial cells, promote developmental activity
of neural stem cells (Shen et al., 2004). In addition, prolif-
eration and function of adult pancreatic b cells are nur-
tured by vascular endothelial components such as lami-
nins (Nikolova et al., 2006). It is thus possible that
specific properties of coronary vessels, in addition to nu-
tritional provision, promote regenerative cardiogenesis.
Our results show that an elaborate sequence of organ-
wide and local responses by epicardial and myocardial
cells orchestrates the vascularized niche. It is tempting
to speculate that the ability to mobilize epicardial cells
and cultivate such a cardiogenic environment is a primary
reason why zebrafish, as opposed to other laboratory
models, effectively regenerate myocardium. Indeed,
mammalian hearts typically show insufficient neovascula-
rization after myocardial infarction. Experimental attemptsto modify this deficiency are underway, including delivery
of growth factors or bone marrow-derived cells that may
promote neovascularization in a paracrine manner or be-
come incorporated into vessels (reviewed in Dimmeler
et al., 2005). Success in these pursuits or by directly utiliz-
ing epicardial cells or their progenitors could prove favor-
able for encouraging regeneration from mammalian car-
diac progenitor cells.
EXPERIMENTAL PROCEDURES
Zebrafish and Ventricular Resection
Outbred Ekkwill strain (EK) or EK/*AB mixed background zebrafish
6–12 months of age were used for ventricular resection surgeries. As
described previously, 20% of ventricular muscle was removed at
the apex with iridectomy scissors (Poss et al., 2002). To visualize spe-
cific cell types, we used cmlc2:nuc-DsRed2 (cmlc2:nRFP; Mably et al.,
2003), cmlc2:EGFP (Burns et al., 2005), fli1:EGFP (Lawson and Wein-
stein, 2002), flk1:EGFP (Jin et al., 2005), or b-actin 2:EGFP (Traver
et al., 2003) transgenic strains or crosses between the strains to gen-
erate double transgenics. All transgenic strains were analyzed as het-
erozygotes in our experiments. All animal procedures were performed
in accordance with Duke University guidelines.
Adult Heat-Induction Experiments
Male hsp70:dn-fgfr1 transgenic and wild-type control animals from the
same parents were injured, allowed overnight recovery from surgery at
room temperature, and then exposed daily to a transient, automated
increase in temperature from 26C to 38C (Lee et al., 2005). With
this protocol, animals remained at 38C for60min each day. All heart
collections were performed 4–5 hr after heat shock. The hsp70:dn-
fgfr1 construct is predicted to heterodimerize with all Fgfr subtypes,
thereby competitively blocking signaling downstream of all Fgfr sub-
types.
Histological Methods
ISH on cryosections of paraformaldehyde-fixed hearts was performed
using digoxygenin-labeled cRNA probes as described (Poss et al.,
2002). For double ISH, digoxygenin-labeled fgfr4 cRNA and fluores-
cein-labeled tbx18 cRNA probes were synthesized using DIG-dUTP
and fluorescein-dUTP (Roche). The TSA biotin system and the TSA
Plus fluorescence system (Perkin Elmer) were used for amplifying the
signal. Whole-mount ISH on intact hearts (performed for experiments
in Figures 3A and 3B) was performed as described (Poss et al.,
2000). Acid fuchsin-orange G staining was performed as described
(Poss et al., 2002). For BrdU-labeling experiments, animals were in-
jected intraperitoneally with 0.05 ml of a 2.5 mg/ml solution of
BrdU dissolved in buffered Hank’s solution. BrdU was injected once
every 24 hr for 3 days prior to heart collection, and immunodetection
of BrdU after ISH was performed as described (Lee et al., 2005). Poly-
clonal antibodies against Mef2 (Santa Cruz Biotechnology) and DsRed
(Clontech) were used for immunofluorescence analyses.
Supplemental Data
Supplemental Data include five figures and one table and can be found
with this article online at http://www.cell.com/cgi/content/full/127/3/
607/DC1/.
ACKNOWLEDGMENTS
We thank Y. Gibert, H. Grandel, A. Nechiporuk, H. Okamoto, I. Scott,
H. Takeda, and D. Yelon for in situ probes; S. Jin and D. Stainier for
flk1:EGFP zebrafish; the Zebrafish International Resource Center for
fli1:EGFP zebrafish; C. Wheeler and V. Tsang for excellent zebrafish
care; and T. Camp, A. McGraw, T. Okubo, and L. Wilson for helpingCell 127, 607–619, November 3, 2006 ª2006 Elsevier Inc. 617
to establish assays. We thank B. Hogan, A. Nechiporuk, S. Odelberg,
D. Yelon, L. Zon, and Poss lab members for helpful comments on the
manuscript. This work was supported by grants to K.D.P. from NIH,
American Heart Association, March of Dimes, and the Whitehead
Foundation.
Received: March 27, 2006
Revised: July 8, 2006
Accepted: August 23, 2006
Published: November 2, 2006
REFERENCES
Akimoto, A., Wada, H., and Hayashi, S. (2005). Enhancer trapping with
a red fluorescent protein reporter in Drosophila. Dev. Dyn. 233,
993–997.
Baird, G.S., Zacharias, D.A., and Tsien, R.Y. (2000). Biochemistry, mu-
tagenesis, and oligomerization of DsRed, a red fluorescent protein
from coral. Proc. Natl. Acad. Sci. USA 97, 11984–11989.
Beltrami, A.P., Barlucchi, L., Torella, D., Baker, M., Limana, F., Chi-
menti, S., Kasahara, H., Rota, M., Musso, E., Urbanek, K., et al.
(2003). Adult cardiac stem cells are multipotent and support myocar-
dial regeneration. Cell 114, 763–776.
Bettencourt-Dias, M., Mittnacht, S., and Brockes, J.P. (2003). Hetero-
geneous proliferative potential in regenerative adult newt cardiomyo-
cytes. J. Cell Sci. 116, 4001–4009.
Bevis, B.J., andGlick, B.S. (2002). Rapidlymaturing variants of the Dis-
cosoma red fluorescent protein (DsRed). Nat. Biotechnol. 20, 83–87.
Brockes, J.P., and Kumar, A. (2005). Appendage regeneration in adult
vertebrates and implications for regenerative medicine. Science 310,
1919–1923.
Burns, C.G., Milan, D.J., Grande, E.J., Rottbauer, W., MacRae, C.A.,
and Fishman, M.C. (2005). High-throughput assay for small molecules
that modulate zebrafish embryonic heart rate. Nat. Chem. Biol. 1,
263–264.
Cai, C.L., Liang, X., Shi, Y., Chu, P.H., Pfaff, S.L., Chen, J., and Evans,
S. (2003). Isl1 identifies a cardiac progenitor population that prolifer-
ates prior to differentiation and contributes a majority of cells to the
heart. Dev. Cell 5, 877–889.
Cao, Y., Zhao, J., Sun, Z., Zhao, Z., Postlethwait, J., and Meng, A.
(2004). fgf17b, a novel member of Fgf family, helps patterning zebrafish
embryos. Dev. Biol. 271, 130–143.
Chen, J.N., and Fishman, M.C. (1996). Zebrafish tinman homolog de-
marcates the heart field and initiates myocardial differentiation. Devel-
opment 122, 3809–3816.
Chen, J.N., Haffter, P., Odenthal, J., Vogelsang, E., Brand, M., van Ee-
den, F.J., Furutani-Seiki, M., Granato, M., Hammerschmidt, M., Hei-
senberg, C.P., et al. (1996). Mutations affecting the cardiovascular sys-
tem and other internal organs in zebrafish. Development 123, 293–302.
Dettman, R.W., Denetclaw, W., Jr., Ordahl, C.P., and Bristow, J.
(1998). Common epicardial origin of coronary vascular smoothmuscle,
perivascular fibroblasts, and intermyocardial fibroblasts in the avian
heart. Dev. Biol. 193, 169–181.
Dimmeler, S., Zeiher, A.M., and Schneider, M.D. (2005). Unchain my
heart: the scientific foundations of cardiac repair. J. Clin. Invest. 115,
572–583.
Echeverri, K., and Tanaka, E.M. (2002). Ectoderm to mesoderm
lineage switching during axolotl tail regeneration. Science 298,
1993–1996.
Eguchi, G., Abe, S.I., and Watanabe, K. (1974). Differentiation of lens-
like structures from newt iris epithelial cells in vitro. Proc. Natl. Acad.
Sci. USA 71, 5052–5056.
Griffin, K.J., Stoller, J., Gibson, M., Chen, S., Yelon, D., Stainier, D.Y.,
and Kimelman, D. (2000). A conserved role for H15-related T-box tran-618 Cell 127, 607–619, November 3, 2006 ª2006 Elsevier Inc.scription factors in zebrafish and Drosophila heart formation. Dev. Biol.
218, 235–247.
Huang, W., Ma, K., Zhang, J., Qatanani, M., Cuvillier, J., Liu, J., Dong,
B., Huang, X., and Moore, D.D. (2006). Nuclear receptor-dependent
bile acid signaling is required for normal liver regeneration. Science
312, 233–236.
Jin, S.W., Beis, D., Mitchell, T., Chen, J.N., and Stainier, D.Y. (2005).
Cellular and molecular analyses of vascular tube and lumen formation
in zebrafish. Development 132, 5199–5209.
Keegan, B.R., Feldman, J.L., Begemann, G., Ingham, P.W., and Yelon,
D. (2005). Retinoic acid signaling restricts the cardiac progenitor pool.
Science 307, 247–249.
Kraus, F., Haenig, B., and Kispert, A. (2001). Cloning and expression
analysis of the mouse T-box gene Tbx18. Mech. Dev. 100, 83–86.
Laugwitz, K.L., Moretti, A., Lam, J., Gruber, P., Chen, Y., Woodard, S.,
Lin, L.Z., Cai, C.L., Lu, M.M., Reth, M., et al. (2005). Postnatal isl1+ car-
dioblasts enter fully differentiated cardiomyocyte lineages. Nature 433,
647–653.
Lavine, K.J., White, A.C., Park, C., Smith, C.S., Choi, K., Long, F., Hui,
C.C., and Ornitz, D.M. (2006). Fibroblast growth factor signals regulate
a wave of Hedgehog activation that is essential for coronary vascular
development. Genes Dev. 20, 1651–1666.
Lawson, N.D., and Weinstein, B.M. (2002). In vivo imaging of embry-
onic vascular development using transgenic zebrafish. Dev. Biol.
248, 307–318.
Lee, Y., Grill, S., Sanchez, A., Murphy-Ryan, M., and Poss, K.D. (2005).
Fgf signaling instructs position-dependent growth rate during zebra-
fish fin regeneration. Development 132, 5173–5183.
Lo, D.C., Allen, F., and Brockes, J.P. (1993). Reversal of muscle differ-
entiation during urodele limb regeneration. Proc. Natl. Acad. Sci. USA
90, 7230–7234.
Mably, J.D., Mohideen, M.A., Burns, C.G., Chen, J.N., and Fishman,
M.C. (2003). heart of glass regulates the concentric growth of the heart
in zebrafish. Curr. Biol. 13, 2138–2147.
Meilhac, S.M., Kelly, R.G., Rocancourt, D., Eloy-Trinquet, S., Nicolas,
J.F., and Buckingham, M.E. (2003). A retrospective clonal analysis of
the myocardium reveals two phases of clonal growth in the developing
mouse heart. Development 130, 3877–3889.
Morabito, C.J., Dettman, R.W., Kattan, J., Collier, J.M., and Bristow, J.
(2001). Positive and negative regulation of epicardial-mesenchymal
transformation during avian heart development. Dev. Biol. 234,
204–215.
Moss, J.B., Xavier-Neto, J., Shapiro, M.D., Nayeem, S.M., McCaffery,
P., Drager, U.C., and Rosenthal, N. (1998). Dynamic patterns of reti-
noic acid synthesis and response in the developing mammalian heart.
Dev. Biol. 199, 55–71.
Nikolova, G., Jabs, N., Konstantinova, I., Domogatskaya, A., Tryggva-
son, K., Sorokin, L., Fassler, R., Gu, G., Gerber, H.P., Ferrara, N., et al.
(2006). The vascular basement membrane: a niche for insulin gene
expression and Beta cell proliferation. Dev. Cell 10, 397–405.
Oberpriller, J.O., and Oberpriller, J.C. (1974). Response of the adult
newt ventricle to injury. J. Exp. Zool. 187, 249–253.
Oh, H., Bradfute, S.B., Gallardo, T.D., Nakamura, T., Gaussin, V.,
Mishina, Y., Pocius, J., Michael, L.H., Behringer, R.R., Garry, D.J.,
et al. (2003). Cardiac progenitor cells from adult myocardium: homing,
differentiation, and fusion after infarction. Proc. Natl. Acad. Sci. U.S.A.
100, 12313–12318.
Olivey, H.E., Compton, L.A., and Barnett, J.V. (2004). Coronary vessel
development: the epicardium delivers. Trends Cardiovasc. Med. 14,
247–251.
Olsen, S.K., Li, J.Y., Bromleigh, C., Eliseenkova, A.V., Ibrahimi, O.A.,
Lao, Z., Zhang, F., Linhardt, R.J., Joyner, A.L., and Mohammadi, M.
(2006). Structural basis by which alternative splicing modulates the or-
ganizer activity of FGF8 in the brain. Genes Dev. 20, 185–198.
Pennisi, D.J., andMikawa, T. (2005). Normal patterning of the coronary
capillary plexus is dependent on the correct transmural gradient of
FGF expression in the myocardium. Dev. Biol. 279, 378–390.
Poss, K.D., Shen, J., Nechiporuk, A., McMahon, G., Thisse, B., Thisse,
C., and Keating, M.T. (2000). Roles for Fgf signaling during zebrafish fin
regeneration. Dev. Biol. 222, 347–358.
Poss, K.D., Wilson, L.G., and Keating, M.T. (2002). Heart regeneration
in zebrafish. Science 298, 2188–2190.
Raya, A., Koth, C.M., Buscher, D., Kawakami, Y., Itoh, T., Raya, R.M.,
Sternik, G., Tsai, H.J., Rodriguez-Esteban, C., and Izpisua-Belmonte,
J.C. (2003). Activation of Notch signaling pathway precedes heart
regeneration in zebrafish. Proc. Natl. Acad. Sci. USA 100 (Suppl 1),
11889–11895.
Reddien, P.W., and Sanchez Alvarado, A. (2004). Fundamentals of
planarian regeneration. Annu. Rev. Cell Dev. Biol. 20, 725–757.
Reese, D.E., Mikawa, T., and Bader, D.M. (2002). Development of the
coronary vessel system. Circ. Res. 91, 761–768.
Rubart, M., and Field, L.J. (2006). Cardiac regeneration: repopulating
the heart. Annu. Rev. Physiol. 68, 29–49.
Scadding, S.R. (1977). Phylogenic distribution of limb regeneration ca-
pacity in adult Amphibia. J. Exp. Zool. 202, 57–68.
Shen, Q., Goderie, S.K., Jin, L., Karanth, N., Sun, Y., Abramova, N.,
Vincent, P., Pumiglia, K., and Temple, S. (2004). Endothelial cells
stimulate self-renewal and expand neurogenesis of neural stem cells.
Science 304, 1338–1340.
Shizuru, J.A., Negrin, R.S., and Weissman, I.L. (2005). Hematopoietic
stem and progenitor cells: clinical and preclinical regeneration of the
hematolymphoid system. Annu. Rev. Med. 56, 509–538.
Stainier, D.Y., Fouquet, B., Chen, J.N., Warren, K.S., Weinstein, B.M.,
Meiler, S.E., Mohideen, M.A., Neuhauss, S.C., Solnica-Krezel, L.,Schier, A.F., et al. (1996). Mutations affecting the formation and func-
tion of the cardiovascular system in the zebrafish embryo. Develop-
ment 123, 285–292.
Taub, R. (2004). Liver regeneration: from myth to mechanism. Nat.
Rev. Mol. Cell Biol. 5, 836–847.
Tevosian, S.G., Deconinck, A.E., Tanaka, M., Schinke, M., Litovsky,
S.H., Izumo, S., Fujiwara, Y., and Orkin, S.H. (2000). FOG-2, a cofactor
for GATA transcription factors, is essential for heart morphogenesis
and development of coronary vessels from epicardium. Cell 101,
729–739.
Traver, D., Paw, B.H., Poss, K.D., Penberthy, W.T., Lin, S., and Zon,
L.I. (2003). Transplantation and in vivo imaging of multilineage engraft-
ment in zebrafish bloodless mutants. Nat. Immunol. 4, 1238–1246.
Verkhusha, V.V., Otsuna, H., Awasaki, T., Oda, H., Tsukita, S., and Ito,
K. (2001). An enhanced mutant of red fluorescent protein DsRed for
double labeling and developmental timer of neural fiber bundle forma-
tion. J. Biol. Chem. 276, 29621–29624.
Verkhusha, V.V., Kuznetsova, I.M., Stepanenko, O.V., Zaraisky, A.G.,
Shavlovsky,M.M., Turoverov, K.K., and Uversky, V.N. (2003). High sta-
bility of Discosoma DsRed as compared to Aequorea EGFP. Biochem-
istry 42, 7879–7884.
Wagers, A.J., Sherwood, R.I., Christensen, J.L., and Weissman, I.L.
(2002). Little evidence for developmental plasticity of adult hematopoi-
etic stem cells. Science 297, 2256–2259.
Wagner, G.P., and Misof, B.Y. (1992). Evolutionary modification of
regenerative capability in vertebrates: a comparative study on teleost
pectoral fin regeneration. J. Exp. Zool. 261, 62–78.
Yelon, D., Ticho, B., Halpern, M.E., Ruvinsky, I., Ho, R.K., Silver, L.M.,
and Stainier, D.Y. (2000). The bHLH transcription factor hand2 plays
parallel roles in zebrafish heart and pectoral fin development. Develop-
ment 127, 2573–2582.Cell 127, 607–619, November 3, 2006 ª2006 Elsevier Inc. 619
